Popular Articles

Heart Patients Are Twice As Likely To Quit Smoking With Intensive In-Hospital Support
A new study in CMAJ (Canadian Medical Association Journal) shows that patients admitted to a hospital with coronary artery disease are twice as likely to quit smoking after receiving intensive smoking cessation support than those receiving minimal support.

Fountain Of Youth? Cutting Calories May Add Years To Your Life
Growing scientific evidence indicates that people who adhere to a special calorie-restricted diet can improve their health and could potentially add years to their lifespan, according to an article in the current issue of Chemical & Engineering News, ACS" weekly newsmagazine.
News of the day
Antiabortion-Rights Group Operation Rescue Considering Purchase Of Tiller's Clinic
Operation Rescue President Troy Newman on Wednesday said that his group is considering trying to purchase murdered abortion provider George Tiller"s Wichita, Kan., clinic, which Tiller"s family permanently closed on Tuesday, the New York Times reports. The clinic is owned by Tiller"s family. The family"s lawyer, Dan Monnat, called Operation Rescue"s proposal "just another irreverent, extremist publicity stunt." He declined to comment further on the situation. The family has not announced its plans for the building and land, which are worth $734,100, according to Sedgwick County, Kan., property records. The clinic has long been a focal point for the antiabortion-rights movement because it was one of the few in the U.S. that offered abortion later in pregnancy. Newman said that he has discussed the possible purchase with only a few members of Operation Rescue"s board but is certain that the funds could be raised if they decide to attempt to buy the clinic. Newman also said that one possibility for the location would be to turn it into a memorial museum to serve as "a tribute to the babies." He denied the claim that his comments are a publicity stunt.According to the Times, the closing of Tiller"s clinic has set off a "flurry of concerns" from abortion-rights advocates that it will be more difficult for women to access abortion services in situations when catastrophic health issues are identified late in pregnancy (Davey, New York Times, 6/11). LeRoy Carhart, a Nebraska abortion provider who worked with Tiller at the clinic, said that he will continue to perform third-trimester abortions in Kansas but did not provide information on where he will practice, the AP/Yahoo! News reports. Although he did not provide details, Carhart said that "there will be a place in Kansas for the later second- and the medically indicated third-trimester patients very soon." He said he has seen an increase in patients at his Nebraska clinic since Tiller"s murder. Carhart traveled to Tiller"s clinic to perform second- and third-trimester abortions because Kansas has less restrictive abortion laws than Nebraska. Carhart said he has not performed any procedures at his clinic after 22 weeks" gestation because his staff is not trained to do them. According to the AP/Yahoo! News, Nebraska law prohibits abortion when a fetus is considered viable. Kansas law, however, allows abortion after 21 weeks" gestation if continuing the pregnancy would endanger the woman"s life or cause "substantial and irreversible impairment" of a major bodily function, which courts have interpreted to include mental health (Gibbs, AP/Yahoo! News, 6/11).Broadcast CoverageThree media outlets on Wednesday reported on issues related to Tiller"s murder. Summaries appear below.~ MSNBC"s "The Rachel Maddow Show": The program included a discussion with Jennifer Boulanger, executive director for the Allentown Women"s Center, about threats to the center since Tiller"s murder (Maddow, "The Rachel Maddow Show," MSNBC, 6/10).~ NPR"s "All Things Considered": The program included a discussion with NPR health policy correspondent Julie Rovner about the correct terminology for referring to abortion later in pregnancy and why the phrase "late-term abortion" is inaccurate (Block, "All Things Considered," NPR, 6/10).~ WBUR"s "On Point": The program included a discussion with the Rev. Katherine Ragsdale -- a board member of NARAL Pro-Choice America and the incoming dean and president of Episcopal Divinity School -- and Jim Wallis -- founder and editor of the progressive evangelical group Sojourners -- about abortion-rights supporters" reaction to violence in the antiabortion-rights movement (Ashbrook, "On Point," WBUR, 6/10).
Diagnostics

New UK Developed Anti-Bacterial Drug {Metallo-Porphyrin} Unveiled At Leading European Microbiology Congress

Yesterday"s 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) conference in Helsinki reported a significant addition to the dwindling number of drugs in the fight against the hospital "Superbug", Methicillin Resistant Staphylococcus aureus (MRSA). UK-based pharmaceutical company Destiny Pharma presented research into the rapid anti-bacterial activity of its latest platform of drugs against Staphylococcus aureus on the second day of the conference. Whilst the company"s lead anti-microbial XF-73 continues on course within Phase I/IIa clinical development, Destiny has now demonstrated the novel anti-bacterial mechanism of action of DPD-207. This is an example of its new platform of Metallo-Porphyrin (MP) drugs which has been proven to act in a similar manner to the XF drug platform. The XF drugs: 1. Kill bacteria extremely quickly (much faster than traditional antibiotics) 2. Bacteria such as MRSA seem unable to become resistant to XF/MP drug action (unlike many antibiotics to which the Superbug can rapidly become resistant) 3. Kill bacteria within biofilms (the protective "jelly" bacteria produce around themselves, which acts as a protective barrier against antibiotics) The MP drugs appear to share many of the same revolutionary and highly advantageous anti-bacterial properties of the XF drugs. The MP drug platform represents a significant expansion of the Destiny Pharma drug portfolio. More information about MRSA In the USA around 126,000 people are hospitalised each year with MRSA-related infections resulting in 19,000 fatalities. In the UK, MRSA causes over 6,000 serious bloodstream infections each year and results in at least 1,600 deaths. Healthcare-associated infections (HCAIs) predominantly caused by MRSA, are estimated to cost the NHS over ÷£1 billion every year and the US economy more than $30 billion More information about the XF series The XF compounds are bactericidal rather than bacteriostatic; killing the bacteria instead of just limiting population growth. These compounds have a unique structure based on a porphyrin core and are chemically distinct from all existing antimicrobial therapies. In laboratory studies, the XFs are active against a wide variety of clinically important gram-positive bacteria, including the most common and problematic MRSA strains and two clinical isolates of Clostridium difficile. Destiny Pharma


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):